Literature DB >> 7921754

Giant cell arteritis in Jerusalem: a 12-year epidemiological study.

M Sonnenblick1, G Nesher, Y Friedlander, A Rubinow.   

Abstract

The prevoting conception of the incidence of giant cell arteritis (GCA) among population underscores the very low incidence of this disease among Jews. We studied the epidemiology, ethnic background, and seasonality of GCA among the Jewish population of Jerusalem. Eighty-four patients with biopsy-proven GCA were identified in a period of 12 yr, from 1980-1991. The age, sex and period-adjusted incidence of GCA was 10.2 per 100,000 population aged > or = 50 yr, approximately 20-fold higher than that reported for the Jewish population in Israel for the years 1960-1978. The female:male ratio was 1.6. A declining trend in the annual incidence was observed for men but not for women. The incidence rate was similar among non-western and western Jews. The onset of GCA was more common during the early summer months (May-June).

Entities:  

Mesh:

Year:  1994        PMID: 7921754     DOI: 10.1093/rheumatology/33.10.938

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

Review 2.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Epidemiology of giant cell arteritis in an Arab population: a 22-year study.

Authors:  Neil R Miller
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

Review 4.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

5.  Ophthalmic presentation of giant cell arteritis in African-Americans.

Authors:  S T Garrity; M Pistilli; M S Vaphiades; N Q Richards; P S Subramanian; P R Rosa; B L Lam; B J Osborne; G T Liu; K E Duncan; R K Shin; N J Volpe; K S Shindler; M S Lee; M L Moster; E H Tracey; S E Cuprill-Nilson; M A Tamhankar
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

Review 6.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

7.  Towards a new clinical spectrum in giant cell arteritis.

Authors:  M A Gonzalez-Gay; R Blanco; M Vazquez-Caruncho
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 8.  Genetic and environmental factors in polymyalgia rheumatica.

Authors:  M A Cimmino
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

9.  Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness.

Authors:  G Nesher; A Rubinow; M Sonnenblick
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

10.  Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

Authors:  M A González-Gay; C Garcia-Porrua; M J Rivas; P Rodriguez-Ledo; J Llorca
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.